Disordered eating associated with higher HbA1c in teens

January 31, 2018

(HealthDay)—For youth with type 1 diabetes, disordered eating behaviors (DEBs) are associated with higher hemoglobin A1c but not with measures of glycemic variability, according to a study published online Jan. 25 in Diabetes Care.

Miriam H. Eisenberg Colman, Ph.D., from the Eunice Kennedy Shriver National Institute of Child Health and Human Development in Bethesda, Md., and colleagues reported DEB and management at baseline and at six, 12, and 18 months for youth (ages 8 to 16) with type 1 diabetes participating in an 18-month behavioral intervention.

The researchers found that the intervention had no effect on DEB (P = 0.84). There were correlations for DEB with higher hemoglobin A1c (P = 0.001), mean sensor glucose (P = 0.001), and percent sensor glucose values >180 mg/dL (P = <0.001), and with lower 1,5-anhydroglucitol (P = 0.01) and worse diabetes adherence (P = 0.03). There was no correlation for DEB with percent sensor glucose values <70 mg/dL or any measures of glycemic variability. A significant DEB × time interaction effect was seen for mean sensor glucose (P = 0.05) and percent sensor glucose values >180 mg/dL (P = 0.04). Throughout the study there was a developmentally expected deterioration in glycemic control for participants reporting less DEB. For participants with more DEB, poor glycemic control was seen at baseline and this persisted through the study.

"Findings show a potential to improve diet quality without increasing DEB and indicate an association of DEB with persistent hyperglycemia but not hypoglycemia or glycemic variability," the authors write.

Explore further: Fasting plasma glucose, HbA1c linked to alzheimer's in T2DM

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Fasting plasma glucose, HbA1c linked to alzheimer's in T2DM

July 25, 2017
(HealthDay)—For patients with type 2 diabetes mellitus (T2DM), fasting plasma glucose (FPG) visit-to-visit variation, represented by the coefficient of variation (CV), and hemoglobin A1c (HbA1c) CV are independently associated ...

Glucose variation doesn't affect microvascular complications

April 18, 2017
(HealthDay)—Measures of glycemic variability in type 1 diabetes, based on complete quarterly 7-point glucose profiles, fail to provide evidence that glycemic variability contributes to the risk of development or progression ...

Continuous subcutaneous insulin infusion bests injections in T2DM

April 7, 2017
(HealthDay)—For patients with type 2 diabetes and hemoglobin A1c (HbA1c) >8 percent following multiple daily injections (MDI), continuous subcutaneous insulin infusion (CSII) is associated with a significantly greater reduction ...

Glycemic variability affects mood and quality of life

May 10, 2012
(HealthDay) -- Glycemic variability appears to be associated with lower quality of life and negative moods in women with type 2 diabetes, according to a study published in the March 30 issue of Diabetes Technology & Therapeutics.

In T2D, glycemic control up with continuous glucose monitoring

August 23, 2017
(HealthDay)—Adults with type 2 diabetes receiving multiple daily insulin injections randomized to continuous glucose monitoring (CGM) have improved glycemic control versus usual care, according to a study published online ...

HbA1c, waist-to-height ratio predict dyslipidemia in T1DM

February 1, 2017
(HealthDay)—For youth with type 1 diabetes, hemoglobin A1c (A1C) and waist-to-height ratio (WHtR) are modifiable risk factors that predict change in dyslipidemia, according to a study published online Jan. 26 in Diabetes ...

Recommended for you

Deep brain stimulation found to improve diabetes symptoms

May 24, 2018
A team of researchers from several institutions in the Netherlands and Yale University in the U.S. has found evidence that suggests deep brain stimulation (DBS) can help treat type 2 diabetes. In their paper published in ...

Women with pregnancy-related diabetes may be at risk for chronic kidney disease

May 21, 2018
Gestational diabetes may predispose women to early-stage kidney damage, a precursor to chronic kidney disease, according to a study by researchers at the National Institutes of Health and other institutions. The study appears ...

Diabetes researchers find switch for fatty liver disease

May 17, 2018
Duke researchers have identified a key fork in the road for the way the liver deals with carbohydrates, fats and protein. They say it could be a promising new target for combating the pandemics of fatty liver disease and ...

New study of youth with type 1 diabetes connects 'honeymoon period' with lower LDL cholesterol

May 17, 2018
A new study by UMass Medical School physician-scientist Benjamin U. Nwosu, MD, finds that children with type 1 diabetes who experienced a partial clinical remission, or "honeymoon phase," had significantly lower low-density ...

"Living drug factories" may one day replace injections

May 17, 2018
Patients with diabetes generally rely on constant injections of insulin to control their disease. But MIT spinout Sigilon Therapeutics is developing an implantable, insulin-producing device that may one day make injections ...

Boosting the effects of vitamin D to tackle diabetes

May 10, 2018
More than 27 million people in the United States are living with type 2 diabetes, according to the Centers for Disease Control and Prevention. As the population ages and a growing percentage of people become overweight or ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.